Clinical utility of [ 18 F]FDG PET/CT in the assessment of mediastinal lymph node disease after neoadjuvant chemoimmunotherapy for non-small cell lung cancer.

Lei ZhangHaoran EJia HuangJunqi WuQiang LiLikun HouChongwu LiChenyang DaiJiajun DengMinglei YangMinjie MaYijiu RenQingquan LuoDeping ZhaoChang Chen

Published in: European radiology (2023)

• PET/CT could serve as an effective non-invasive tool for predicting ypN2 diseases. • The ypN2 patients with PET/CT-N2( +) were a strong and independent prognostic factor. • The application of PET/CT for restaging should be encouraged in clinical practice.

Keyphrases

pet ct
lymph node
prognostic factors
clinical practice
positron emission tomography
neoadjuvant chemotherapy
sentinel lymph node
rectal cancer
locally advanced
radiation therapy